Metraipolis › archive › dc_208ee19aa986
Real-world pharmacovigilance of risperidone: Analysis based on FAERS reports from physicians and pharmacists — Europe PMC PMID:41105623
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41105623
- DOI
- 10.1371/journal.pone.0331983
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:46:48.866Z
- SHA-256 of the archived text
73f8c69429fa4d1601a600d64bd5f20e3b0b9a8c38260d157ca1da470881ec4f- Stable URL of this page
https://metraipolis.com/documento/dc_208ee19aa986
How to cite
Real-world pharmacovigilance of risperidone: Analysis based on FAERS reports from physicians and pharmacists — Europe PMC PMID:41105623 — Europe PMC (en), https://europepmc.org/article/MED/41105623 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_208ee19aa986 (Metraipolis archive dc_208ee19aa986, sha256 73f8c69429fa4d1601a600d64bd5f20e3b0b9a8c38260d157ca1da470881ec4f)
BibTeX
@misc{dc208ee19aa986,
title = {Real-world pharmacovigilance of risperidone: Analysis based on FAERS reports from physicians and pharmacists — Europe PMC PMID:41105623},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41105623},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_208ee19aa986; sha256 73f8c69429fa4d1601a600d64bd5f20e3b0b9a8c38260d157ca1da470881ec4f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41105623. Agents can read the archived copy with the MCP tool read_document.